SedMed has secured a $4 million investment led by 108 BioCapital to expand access to its non-electric toilet lift, a device made by the Milford company to help older adults and individuals with limited mobility sit and stand more safely and independently while reducing strain on caregivers.

The SedMed Toilet Lift attaches to most standard toilets and provides adjustable sit-to-stand assistance without electricity, batteries or bathroom remodeling. 108 BioCapital, a U.S.-based private equity firm focused on growth-stage investments in biotech and medtech companies addressing high-impact unmet medical needs, is leading the round.

Sasha Bakhru, Managing Partner of 108 BioCapital, said the investment reflects confidence in SedMed's approach to an overlooked challenge. "SedMed is addressing an important and often overlooked challenge for older adults, individuals with limited mobility and their caregivers. The company has developed an intuitive, non-electric solution with the potential to improve safety, preserve independence and reduce caregiver burden across home and healthcare settings."

SedMed plans to use the investment to accelerate commercial expansion, grow its distribution and channel partnerships, advance its intellectual property portfolio and conduct additional hospital-based studies.

The company's hospital adoption to date factored into 108 BioCapital's decision to back this expansion. "SedMed's adoption across more than 40 hospital systems demonstrates strong demand for its solution and validates the important role it can play in addressing a significant challenge for healthcare providers," said Shahryar Oveissi, General Partner of 108 BioCapital. "That momentum also sets the stage for SedMed to become a trusted solution for older adults living at home, where physical limitations, cognitive decline and environmental barriers can increase the risk of accidents and place added strain on caregivers."

SedMed's device is designed for use in homes, senior living communities and healthcare settings, supporting independence and dignity for people with limited mobility.

For SedMed's leadership, the funding affirms the company's progress to date. "This investment represents an important milestone for SedMed as we work to make safer bathroom mobility accessible to more people," said Jeremy Bronen, CEO of SedMed. "108 BioCapital brings healthcare expertise and a shared commitment to supporting technologies that can meaningfully improve the lives of patients and caregivers. This funding will allow us to expand our commercial reach, strengthen our distribution network and build additional evidence demonstrating the value SedMed can provide to healthcare organizations."

The funding gives SedMed capital to scale its hospital-proven device and extend safety and independence benefits to more people managing mobility challenges at home.